Institute of Cancer Research granted Oxford Gene an exclusive, worldwide license to develop and commercialize a panel of diagnostic and prognostic microRNA biomarkers for prostate cancer

The Institute of Cancer Research

U.K. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Oxford Gene Technology

U.K. / Tools, Services, and Manufacturing

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced